Loading…

Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?

The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer. All child...

Full description

Saved in:
Bibliographic Details
Published in:Turkish archives of pediatrics 2023-01, Vol.58 (1), p.75-79
Main Authors: Koç, Begüm Şirin, Tekkeşin, Funda, Haccaloğlu, Elif Ezgi, Beyter, Büşra, Aydoğdu, Selime, Kılıç, Suar Çakı
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23
cites
container_end_page 79
container_issue 1
container_start_page 75
container_title Turkish archives of pediatrics
container_volume 58
creator Koç, Begüm Şirin
Tekkeşin, Funda
Haccaloğlu, Elif Ezgi
Beyter, Büşra
Aydoğdu, Selime
Kılıç, Suar Çakı
description The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer. All children diagnosed with cancer and followed up in our clinic between 2017 and 2022 were included. Patients with a diagnosis of acute/chronic leukemia were excluded. Age, gender, cancer type, duration of complaints, and presence of metastasis at diagnosis of the children were recorded. The duration of complaints and presence of metastasis at diagnosis were compared statistically before and after March 11, 2020, the start point of the COVID-19 pandemic in our country. A total of 161 patients diagnosed with cancer were analyzed retrospectively; 61% of patients were males and 39% were females. These patients were diagnosed with brain tumors (23.6%), lymphomas (23%), neuroblastoma (13.7%), rhabdomyosarcomas (10.6%), Ewing's sarcoma (4.3%), osteosarcoma (3.7%), Wilm's tumor (3.7%), and germ cell tumors (3.1%). The duration of complaint was longer during the pandemic than before the pandemic (median: 45 days vs. 30 days) (P < .05). The presence of metastases at diagnosis was 45.3% in the prepandemic period, while it was 40% during the pandemic with no statistical difference (P > .5). We concluded that the duration of complaint before diagnosis was longer during the pandemic, while this delay did not affect the metastasis rate at diagnosis in children with cancer. The high rates of distant metastases in newly diagnosed patients both before and during the pandemic suggest that more studies are needed to diagnose these patients earlier.
doi_str_mv 10.5152/TurkArchPediatr.2022.22224
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9885817</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2760820562</sourcerecordid><originalsourceid>FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23</originalsourceid><addsrcrecordid>eNpVkN9LwzAQgIMobsz9CxJ88qUzSZsmeVFG64_BYHuYPgklbdM12iYzaYX99246Zd7LHdzd93EHwBVGE4opuVn17n3qinqpSi07NyGIkAnZRXQChoRRFsSExqdH9QCMvX9DCBEmwihm52AQxlRwgukQvE7NFibWFMoZOM1t38FUNXLroTawqxVMtVwb67WHtoJJrZuytraEidyveJj2Tpv192SyeJmlARZwKU2pWl3cXYCzSjZejQ95BJ4f7lfJUzBfPM6S6TwoIhF2QSxQhYXkBalYHEUUR6gMc6kKwktBsRIM5wohTCqO6e6MHOcSK05DhTljkoQjcPvD3fR5q8pCmc7JJts43Uq3zazU2f-O0XW2tp-Z4JxyzHaA6wPA2Y9e-S5rtS9U00ijbO8zwmLECaLx3nV57PqT_L40_ALw7Hyw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2760820562</pqid></control><display><type>article</type><title>Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?</title><source>Open Access: PubMed Central</source><source>DOAJ Directory of Open Access Journals</source><creator>Koç, Begüm Şirin ; Tekkeşin, Funda ; Haccaloğlu, Elif Ezgi ; Beyter, Büşra ; Aydoğdu, Selime ; Kılıç, Suar Çakı</creator><creatorcontrib>Koç, Begüm Şirin ; Tekkeşin, Funda ; Haccaloğlu, Elif Ezgi ; Beyter, Büşra ; Aydoğdu, Selime ; Kılıç, Suar Çakı</creatorcontrib><description>The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer. All children diagnosed with cancer and followed up in our clinic between 2017 and 2022 were included. Patients with a diagnosis of acute/chronic leukemia were excluded. Age, gender, cancer type, duration of complaints, and presence of metastasis at diagnosis of the children were recorded. The duration of complaints and presence of metastasis at diagnosis were compared statistically before and after March 11, 2020, the start point of the COVID-19 pandemic in our country. A total of 161 patients diagnosed with cancer were analyzed retrospectively; 61% of patients were males and 39% were females. These patients were diagnosed with brain tumors (23.6%), lymphomas (23%), neuroblastoma (13.7%), rhabdomyosarcomas (10.6%), Ewing's sarcoma (4.3%), osteosarcoma (3.7%), Wilm's tumor (3.7%), and germ cell tumors (3.1%). The duration of complaint was longer during the pandemic than before the pandemic (median: 45 days vs. 30 days) (P &lt; .05). The presence of metastases at diagnosis was 45.3% in the prepandemic period, while it was 40% during the pandemic with no statistical difference (P &gt; .5). We concluded that the duration of complaint before diagnosis was longer during the pandemic, while this delay did not affect the metastasis rate at diagnosis in children with cancer. The high rates of distant metastases in newly diagnosed patients both before and during the pandemic suggest that more studies are needed to diagnose these patients earlier.</description><identifier>ISSN: 2757-6256</identifier><identifier>EISSN: 2757-6256</identifier><identifier>DOI: 10.5152/TurkArchPediatr.2022.22224</identifier><identifier>PMID: 36598215</identifier><language>eng</language><publisher>Turkey: Turkish Pediatrics Association</publisher><subject>Original</subject><ispartof>Turkish archives of pediatrics, 2023-01, Vol.58 (1), p.75-79</ispartof><rights>2023 authors 2023 authors</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885817/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885817/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36598215$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koç, Begüm Şirin</creatorcontrib><creatorcontrib>Tekkeşin, Funda</creatorcontrib><creatorcontrib>Haccaloğlu, Elif Ezgi</creatorcontrib><creatorcontrib>Beyter, Büşra</creatorcontrib><creatorcontrib>Aydoğdu, Selime</creatorcontrib><creatorcontrib>Kılıç, Suar Çakı</creatorcontrib><title>Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?</title><title>Turkish archives of pediatrics</title><addtitle>Turk Arch Pediatr</addtitle><description>The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer. All children diagnosed with cancer and followed up in our clinic between 2017 and 2022 were included. Patients with a diagnosis of acute/chronic leukemia were excluded. Age, gender, cancer type, duration of complaints, and presence of metastasis at diagnosis of the children were recorded. The duration of complaints and presence of metastasis at diagnosis were compared statistically before and after March 11, 2020, the start point of the COVID-19 pandemic in our country. A total of 161 patients diagnosed with cancer were analyzed retrospectively; 61% of patients were males and 39% were females. These patients were diagnosed with brain tumors (23.6%), lymphomas (23%), neuroblastoma (13.7%), rhabdomyosarcomas (10.6%), Ewing's sarcoma (4.3%), osteosarcoma (3.7%), Wilm's tumor (3.7%), and germ cell tumors (3.1%). The duration of complaint was longer during the pandemic than before the pandemic (median: 45 days vs. 30 days) (P &lt; .05). The presence of metastases at diagnosis was 45.3% in the prepandemic period, while it was 40% during the pandemic with no statistical difference (P &gt; .5). We concluded that the duration of complaint before diagnosis was longer during the pandemic, while this delay did not affect the metastasis rate at diagnosis in children with cancer. The high rates of distant metastases in newly diagnosed patients both before and during the pandemic suggest that more studies are needed to diagnose these patients earlier.</description><subject>Original</subject><issn>2757-6256</issn><issn>2757-6256</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkN9LwzAQgIMobsz9CxJ88qUzSZsmeVFG64_BYHuYPgklbdM12iYzaYX99246Zd7LHdzd93EHwBVGE4opuVn17n3qinqpSi07NyGIkAnZRXQChoRRFsSExqdH9QCMvX9DCBEmwihm52AQxlRwgukQvE7NFibWFMoZOM1t38FUNXLroTawqxVMtVwb67WHtoJJrZuytraEidyveJj2Tpv192SyeJmlARZwKU2pWl3cXYCzSjZejQ95BJ4f7lfJUzBfPM6S6TwoIhF2QSxQhYXkBalYHEUUR6gMc6kKwktBsRIM5wohTCqO6e6MHOcSK05DhTljkoQjcPvD3fR5q8pCmc7JJts43Uq3zazU2f-O0XW2tp-Z4JxyzHaA6wPA2Y9e-S5rtS9U00ijbO8zwmLECaLx3nV57PqT_L40_ALw7Hyw</recordid><startdate>20230101</startdate><enddate>20230101</enddate><creator>Koç, Begüm Şirin</creator><creator>Tekkeşin, Funda</creator><creator>Haccaloğlu, Elif Ezgi</creator><creator>Beyter, Büşra</creator><creator>Aydoğdu, Selime</creator><creator>Kılıç, Suar Çakı</creator><general>Turkish Pediatrics Association</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230101</creationdate><title>Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?</title><author>Koç, Begüm Şirin ; Tekkeşin, Funda ; Haccaloğlu, Elif Ezgi ; Beyter, Büşra ; Aydoğdu, Selime ; Kılıç, Suar Çakı</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Original</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koç, Begüm Şirin</creatorcontrib><creatorcontrib>Tekkeşin, Funda</creatorcontrib><creatorcontrib>Haccaloğlu, Elif Ezgi</creatorcontrib><creatorcontrib>Beyter, Büşra</creatorcontrib><creatorcontrib>Aydoğdu, Selime</creatorcontrib><creatorcontrib>Kılıç, Suar Çakı</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Turkish archives of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koç, Begüm Şirin</au><au>Tekkeşin, Funda</au><au>Haccaloğlu, Elif Ezgi</au><au>Beyter, Büşra</au><au>Aydoğdu, Selime</au><au>Kılıç, Suar Çakı</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?</atitle><jtitle>Turkish archives of pediatrics</jtitle><addtitle>Turk Arch Pediatr</addtitle><date>2023-01-01</date><risdate>2023</risdate><volume>58</volume><issue>1</issue><spage>75</spage><epage>79</epage><pages>75-79</pages><issn>2757-6256</issn><eissn>2757-6256</eissn><abstract>The lockdown precautions during the COVID-19 pandemic led to concerns about the delayed diagnosis of malignancies. This study aimed to compare the duration of complaints at home and the presence of metastasis at diagnosis during the pre-pandemic and pandemic period in children with cancer. All children diagnosed with cancer and followed up in our clinic between 2017 and 2022 were included. Patients with a diagnosis of acute/chronic leukemia were excluded. Age, gender, cancer type, duration of complaints, and presence of metastasis at diagnosis of the children were recorded. The duration of complaints and presence of metastasis at diagnosis were compared statistically before and after March 11, 2020, the start point of the COVID-19 pandemic in our country. A total of 161 patients diagnosed with cancer were analyzed retrospectively; 61% of patients were males and 39% were females. These patients were diagnosed with brain tumors (23.6%), lymphomas (23%), neuroblastoma (13.7%), rhabdomyosarcomas (10.6%), Ewing's sarcoma (4.3%), osteosarcoma (3.7%), Wilm's tumor (3.7%), and germ cell tumors (3.1%). The duration of complaint was longer during the pandemic than before the pandemic (median: 45 days vs. 30 days) (P &lt; .05). The presence of metastases at diagnosis was 45.3% in the prepandemic period, while it was 40% during the pandemic with no statistical difference (P &gt; .5). We concluded that the duration of complaint before diagnosis was longer during the pandemic, while this delay did not affect the metastasis rate at diagnosis in children with cancer. The high rates of distant metastases in newly diagnosed patients both before and during the pandemic suggest that more studies are needed to diagnose these patients earlier.</abstract><cop>Turkey</cop><pub>Turkish Pediatrics Association</pub><pmid>36598215</pmid><doi>10.5152/TurkArchPediatr.2022.22224</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2757-6256
ispartof Turkish archives of pediatrics, 2023-01, Vol.58 (1), p.75-79
issn 2757-6256
2757-6256
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9885817
source Open Access: PubMed Central; DOAJ Directory of Open Access Journals
subjects Original
title Any Concern About Delays in the Diagnosis of Childhood Cancers During the COVID-19 Pandemic?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T19%3A20%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Any%20Concern%20About%20Delays%20in%20the%20Diagnosis%20of%20Childhood%20Cancers%20During%20the%20COVID-19%20Pandemic?&rft.jtitle=Turkish%20archives%20of%20pediatrics&rft.au=Ko%C3%A7,%20Beg%C3%BCm%20%C5%9Eirin&rft.date=2023-01-01&rft.volume=58&rft.issue=1&rft.spage=75&rft.epage=79&rft.pages=75-79&rft.issn=2757-6256&rft.eissn=2757-6256&rft_id=info:doi/10.5152/TurkArchPediatr.2022.22224&rft_dat=%3Cproquest_pubme%3E2760820562%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c493t-690f19a8c2f76445140d3baec28d951e971be0012f815002b1ba1e853e1877a23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2760820562&rft_id=info:pmid/36598215&rfr_iscdi=true